文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

接受维持性血液透析患者临终关怀住院时长与医疗资源利用及医疗保险费用的关联

Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
PubMed 文献 · JAMA Intern Med · 2018-01-01
一句话结论接受维持性血液透析的医疗保险受益人中,41.5%的临终关怀使用者在死亡前3天内才入组,其住院和ICU入住率反而高于未使用临终关怀者,临终关怀使用并未带来有意义的资源利用和费用改变。

该横断面观察研究基于美国肾脏数据系统登记库,纳入2000年1月1日至2014年12月31日死亡的全部770 191例接受维持性血液透析且参加按服务付费医疗保险的患者。20%的队列成员死亡时正在接受临终关怀服务,其中41.5%的临终关怀时长不足3天。调整分析显示,与未接受临终关怀者相比,临终关怀时长不足3天者院内死亡(13.5% vs 55.1%,P<.001)和生命最后一个月接受有创操作(17.7% vs 31.6%,P<.001)的比例更低,但住院率(83.6% vs 74.4%,P<.001)和ICU入住率(54.0% vs 51.0%,P<.001)更高,生命最后一周的医疗保险费用相似($10 756 vs $10 871,P=.08)。临终关怀时长超过3天者资源利用和费用进行性降低,死亡前15天以上转诊者住院率35.1%、ICU入住率16.7%,生命最后一周平均费用$3221。

要点

  • 接受维持性血液透析的医疗保险受益人中,仅20%死亡时正在接受临终关怀服务,其中41.5%的临终关怀时长不足3天。
  • 临终关怀时长不足3天者与未接受临终关怀者相比,院内死亡(13.5% vs 55.1%,P<.001)和生命最后一个月接受有创操作(17.7% vs 31.6%,P<.001)的比例更低。
  • 临终关怀时长不足3天者与未接受临终关怀者相比,住院率(83.6% vs 74.4%,P<.001)和ICU入住率(54.0% vs 51.0%,P<.001)更高,生命最后一周医疗保险费用相似($10 756 vs $10 871,P=.08)。
  • 临终关怀时长超过3天者资源利用和费用进行性降低,死亡前15天以上转诊者住院率35.1%、ICU入住率16.7%,生命最后一周平均费用$3221。
  • 作者认为,若不解决更及时转诊的障碍,增加临终关怀使用可能不会转化为该人群临终医疗资源利用、费用和医疗质量的有意义改变。

适用人群与场景

  • 美国肾脏数据系统登记库中2000年1月1日至2014年12月31日死亡的全部770 191例接受维持性血液透析且参加按服务付费医疗保险的终末期肾病患者。

研究设计与关键结果

  • 研究类型:横断面观察研究,基于美国肾脏数据系统登记库,纳入770 191例接受维持性血液透析且参加按服务付费医疗保险、于2000年1月1日至2014年12月31日死亡的患者;平均(SD)年龄74.8(11.0)岁,53.7%为男性。
  • 20%的队列成员死亡时正在接受临终关怀服务,其中41.5%的临终关怀时长不足3天。
  • 调整分析:与未接受临终关怀者相比,临终关怀时长不足3天者院内死亡比例更低(13.5% vs 55.1%,P<.001),生命最后一个月接受有创操作的比例更低(17.7% vs 31.6%,P<.001)。
  • 调整分析:与未接受临终关怀者相比,临终关怀时长不足3天者住院率更高(83.6% vs 74.4%,P<.001),ICU入住率更高(54.0% vs 51.0%,P<.001),生命最后一周医疗保险费用相似($10 756 vs $10 871,P=.08)。
  • 临终关怀时长超过3天与资源利用和费用进行性降低相关,死亡前15天以上转诊者生命最后一个月住院率35.1%、ICU入住率16.7%,生命最后一周平均医疗保险费用$3221。

证据类型、等级与局限

  • 证据类型:横断面观察研究,基于美国肾脏数据系统登记库。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,若不解决更及时转诊的障碍,增加临终关怀使用可能不会转化为该人群临终医疗资源利用、费用和医疗质量的有意义改变。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Patients with end-stage renal disease are less likely to use hospice services than other patients with advanced chronic illness. Little is known about the timing of hospice referral in this population and its association with health care utilization and costs.

OBJECTIVE: To examine the association between hospice length of stay and health care utilization and costs at the end of life among Medicare beneficiaries who had received maintenance hemodialysis.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional observational study was conducted via the United States Renal Data System registry. Participants were all 770 191 hemodialysis patients in the registry who were enrolled in fee-for-service Medicare and died between January 1, 2000, and December 31, 2014. The dates of analysis were April 2016 to December 2017.

MAIN OUTCOMES AND MEASURES: Hospital admission, intensive care unit (ICU) admission, and receipt of an intensive procedure during the last month of life; death in the hospital; and costs to the Medicare program in the last week of life.

RESULTS: Among 770 191 patients, the mean (SD) age was 74.8 (11.0) years, and 53.7% were male. Twenty percent of cohort members were receiving hospice services when they died. Of these, 41.5% received hospice for 3 days or fewer. In adjusted analyses, compared with patients who did not receive hospice, those enrolled in hospice for 3 days or fewer were less likely to die in the hospital (13.5% vs 55.1%; P < .001) or to undergo an intensive procedure in the last month of life (17.7% vs 31.6%; P < .001) but had higher rates of hospitalization (83.6% vs 74.4%; P < .001) and ICU admission (54.0% vs 51.0%; P < .001) and similar Medicare costs in the last week of life ($10 756 vs $10 871; P = .08). Longer lengths of stay in hospice beyond 3 days were associated with progressively lower rates of utilization and costs, especially for those referred more than 15 days before death (35.1% hospitalized and 16.7% admitted to an ICU in the last month of life; the mean Medicare costs in the last week of life were $3221).

CONCLUSIONS AND RELEVANCE: Overall, 41.5% of hospice enrollees who had been treated with hemodialysis for their end-stage renal disease entered hospice within 3 days of death. Although less likely to die in the hospital and to receive an intensive procedure, these patients were more likely than those not enrolled in hospice to be hospitalized and admitted to the ICU, and they had similar Medicare costs. Without addressing barriers to more timely referral, greater use of hospice may not translate into meaningful changes in patterns of health care utilization, costs, and quality of care at the end of life in this population.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Wachterman MW, Hailpern SM, Keating NL, et al. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis. JAMA Intern Med. 2018. PMID: 29710217. doi:10.1001/jamainternmed.2018.0256

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。